NYSE: HLNHaleon PLC Stock
$8.41+0.09 (+1.08%)
Updated May 15, 2024
HLN Price
$8.41
Fair Value Price
N/A
Market Cap
$38.83B
52 Week Low
$7.70
52 Week High
$8.96
P/E
29.1x
P/B
1.85x
P/S
2.66x
PEG
1.11x
Dividend Yield
0.55%
Revenue
$14.31B
Earnings
$1.33B
Gross Margin
59.7%
Operating Margin
17.11%
Profit Margin
9.3%
Debt to Equity
1.04
Operating Cash Flow
$3B
Beta
0.43
Next Earnings
N/A
Ex-Dividend
Mar 14, 2024
Next Dividend
May 16, 2024
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HLN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HLN ($8.41) is trading above its intrinsic value of $4.23, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HLN is good value based on its earnings relative to its share price (29.1x), compared to the US market average (31.36x)
P/E vs Market Valuation
HLN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more HLN due diligence checks available for Premium users.
Be the first to know about important HLN news, forecast changes, insider trades & much more!
HLN News
Valuation
HLN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.1x
Industry
-1.36x
Market
31.36x
HLN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HLN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
HLN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.85x
Industry
2.21x
HLN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HLN price to earnings growth (PEG)
For valuing profitable companies with growth potential
HLN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
HLN's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
HLN's Earnings (EBIT) of $2.45B... subscribe to Premium to read more.
Interest Coverage Financials
HLN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$43.1B
Liabilities
$21.9B
Debt to equity
1.04
HLN's short-term assets ($6.10B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HLN's long-term liabilities ($16.06B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HLN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
HLN's operating cash flow ($2.66B)... subscribe to Premium to read more.
Debt Coverage Financials
HLN vs Pharmaceutical Stocks
Haleon Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.